Volume : IX, Issue : VIII, August - 2020

Bilastine used in treatment of Allergic Rhinitis and Urticaria

Mustfa Ali, Mohammad Amir Suhail, Sarita Jangra Bhyan

Abstract :

Bilastin is a new approved second generation oral H1 Antihistaminic drug which is generally used in several countries for symptomatic treatment of Allergic Rhinitis (AR), Chronic Urticaria (CU) and hives. Oral bilastine is a non–sedating H1 antihistaminic antagonist. H1–receptor played most vital role in control allergic inflammation by directly interfering with histamine H1 receptor. Allergic rhinitis is not a serious disease but it is globally health problem. Bilastine does not cross blood ain barrier (BBB). Bilastine has not cytochrome p450 activity. Absolute bioavailability of Bilastine 60 – 61 %. Bilastine bioavailability much more in fasting as compare to with meal. With meal decrease the absorption time of bilastine and time increase to reach maximum concentration (Cmax). Bilastine have a great affinity to protein binding 84–94%. Bilastine approximately 95 % excreted out, faeces or stool (67%), urine (33%).

Keywords :

Article: Download PDF    DOI : 10.36106/ijsr  

Cite This Article:

BILASTINE USED IN TREATMENT OF ALLERGIC RHINITIS AND URTICARIA, Mustfa Ali, Mohammad Amir Suhail, Sarita Jangra Bhyan INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH : Volume-9 | Issue-8 | August-2020

Number of Downloads : 183

References :